Filtered By:
Therapy: Statin Therapy

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 220 results found since Jan 2013.

Beyond heart health: Could your statin help prevent liver cancer?
Liver cancer is hard to treat. It’s a top-five cause of cancer-related death worldwide and a growing cause of cancer-related deaths in the United States. Since liver cancer is often found at a late stage, when treatment has limited benefit, there has been increasing interest in prevention. That’s where statin medications might come in. Liver cancer is usually caused by chronic liver disease, so an important way to prevent liver cancer is to treat the underlying trigger. For example, curing hepatitis C infection — an important cause of chronic liver disease — reduces the risk of liver cancer. However, if the liver d...
Source: Harvard Health Blog - January 27, 2020 Category: Consumer Health News Authors: Irun Bhan, MD Tags: Cancer Drugs and Supplements Health Source Type: blogs

Long-term statin use protects against prostate cancer death
Statins and other drugs that lessen cardiovascular disease risk by lowering blood lipids rank among the world’s most prescribed medications. And for the men who take them, accumulating evidence has for years pointed to another added benefit: a lower risk of developing prostate cancer. Now researchers are reporting that long-term statin use (more than 10 years) can also reduce the odds of a prostate cancer death. The new findings come from a study led by Alison Mondul, a cancer epidemiologist at the University of Michigan School of Public Health. Mondul says that most men develop slow-growing, indolent prostate cancers th...
Source: Harvard Health Blog - January 7, 2019 Category: Consumer Health News Authors: Charlie Schmidt Tags: Living With Prostate Cancer Prostate Knowledge HPK Source Type: blogs

Fight Aging! Newsletter, July 31st 2023
In conclusion, an SBP level below 130 mmHg was found to be associated with longevity among older women. The longer SBP was controlled at a level between 110 and 130 mmHg, the higher the survival probability to age 90. Preventing age-related rises in SBP and increasing the time with controlled BP levels constitute important measures for achieving longevity. « Back to Top
Source: Fight Aging! - July 30, 2023 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Fight Aging! Newsletter, June 6th 2016
This study teaches us that poor wound healing and wrinkling and sagging that occur in aging skin share similar mechanisms." Reduced cell cohesiveness of outgrowths from eccrine sweat glands delays wound closure in elderly skin Human skin heals more slowly in aged vs. young adults, but the mechanism for this delay is unclear. In humans, eccrine sweat glands (ESGs) and hair follicles underlying wounds generate cohesive keratinocyte outgrowths that expand to form the new epidermis. Our results confirm that the outgrowth of cells from ESGs is a major feature of repair in young skin. Strikingly, in aged skin, ...
Source: Fight Aging! - June 5, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Fight Aging! Newsletter, December 3rd 2018
This article, however, is more of a commentary on high level strategy and the effects of regulation, coupled with a desire to forge ahead rather than hold back in the matter of treating aging, thus I concur with much more of what is said than is usually the case. For decades, one of the most debated questions in gerontology was whether aging is a disease or the norm. At present, excellent reasoning suggests aging should be defined as a disease - indeed, aging has been referred to as "normal disease." Aging is the sum of all age-related diseases and this sum is the best biomarker of aging. Aging and its diseases ar...
Source: Fight Aging! - December 2, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Fight Aging! Newsletter, September 9th 2019
We examined human lung tissue from COPD patients and normal control subjects, and found a substantial increase in p16-expressing alveolar cells in COPD patients. Using a transgenic mouse deficient for p16, we demonstrated that lungs of mice lacking p16 were structurally and functionally resistant to CS-induced emphysema due to activation of IGF1/Akt regenerative and protective signaling. Fat Tissue Surrounds Skeletal Muscle to Accelerate Atrophy in Aging and Obesity https://www.fightaging.org/archives/2019/09/fat-tissue-surrounds-skeletal-muscle-to-accelerate-atrophy-in-aging-and-obesity/ Researchers her...
Source: Fight Aging! - September 8, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Fight Aging! Newsletter, March 1st 2021
This study may have important implications for preventing cell senescence and aging-induced tendinopathy, as well as for the selection of novel therapeutic targets of chronic tendon diseases. Our results showed that the treatment of bleomycin, a DNA damaging agent, induced rat patellar TSC (PTSC) cellular senescence. The senescence was characterized by an increase in the senescence-associated β-galactosidase activity, as well as senescence-associated changes in cell morphology. On the other hand, rapamycin could extend lifespan in multiple species, including yeast, fruit flies, and mice, by decelerating DNA damage ...
Source: Fight Aging! - February 28, 2021 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Weekly Roundup – October 18, 2013
The major headlines of this week include: the government shutdown ending, the debt ceiling being dealt with (at least for now) and Obamacare. While you were busy staying on top of these issues you may have missed the health care related stories below. Here is a scary finding; some individuals just have a darker outlook on the world than others and they might not have any control over it. The Washington Post talks about how a group of scientists found what people observe may depend on their genetic blueprint and that a particular gene could also influence where people focus their eyes and attention. The New York Times look...
Source: Disruptive Women in Health Care - October 18, 2013 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Roundup breast cancer National Breast Cancer Awareness Month NBC new york times NPR Washington Post Source Type: blogs

Top Companies in Genomics
From portable genome sequencers until genetic tests revealing distant relations with Thomas Jefferson, genomics represents a fascinatingly innovative area of healthcare. As the price of genome sequencing has been in free fall for years, the start-up scene is bursting from transformative power. Let’s look at some of the most amazing ventures in genomics! The amazing journey of genome sequencing Genome sequencing has been on an amazing scientific as well as economic journey for the last three decades. The Human Genome Project began in 1990 with the aim of mapping the whole structure of the human genome and sequencing it. ...
Source: The Medical Futurist - May 30, 2017 Category: Information Technology Authors: nora Tags: Genomics Personalized Medicine AI artificial intelligence bioinformatics cancer DNA dna testing DTC gc3 genetic disorders genetics genome sequencing personal genomics precision medicine Source Type: blogs

RAS/MAPK Pathway Inhibition as an Example of the Way in Which Cancer Research Informs Aging Research
A sizable number of potential approaches to slowing aging via metabolic manipulation were first tested in the cancer research community. In part, this is because that side of the research community has tested near every compound in the libraries at some point in time, but it is also the case there are deep ties between approaches that might impact cancer and changes that might slow aging. This is particularly the case in the matter of cellular senescence, of great relevance to both cancer and aging, and the first senolytic drugs to clear senescent cells had already seen some success in the cancer field. In at least one cas...
Source: Fight Aging! - October 10, 2022 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs

The Palbociclib Saga: Or Why We Need a Lot of Drug Companies
Science has an article by journalist Ken Garber on palbociclib, the Pfizer CDK4 compound that came up here the other day when we were discussing their oncology portfolio. You can read up on the details of how the compound was put in the fridge for several years, only to finally emerge as one of the company's better prospects. The roots of the project go back to about 1995 at Parke-Davis: Because the many CDK family members are almost identical, “creating a truly selective CDK4 inhibitor was very difficult,” says former Parke-Davis biochemist Dave Fry, who co-chaired the project with chemist Peter Toogood. “A lot of ...
Source: In the Pipeline - August 22, 2014 Category: Chemists Tags: Cancer Source Type: blogs

Statins and Cancer
Numerous reports have been published in the medical literature suggesting that the use of statins may be associated with a reduced risk of certain types of cancer. Numerous other reports have said, in contrast, that statins have no effect on cancer risk.  Given these conflicting medical studies, what do the experts currently say about statins and cancer?...Read Full Post
Source: About.com Heart Disease - April 12, 2013 Category: Cardiology Source Type: blogs

There is no magic pill! Sorry!
I admit I often ask my doctors for a magic wand to make bad things go away. They tell me they cannot provide it no matter how nicely I ask. There is not a magic pill, no matter what the pharmaceutical industry wants to make us think.In a perfect world, I would like to have a magic pill or magic wand for the following: breast cancer, thyroid cancer, rheumatoid arthritis, degenerating disk disease, and fibromyalgia. None exist. So I am whing.The use of tamoxifen to help reduce breast cancer occurrence in high risk patients is a smart idea. It is a relatively small portion of the population and something that can't really be ...
Source: Caroline's Breast Cancer Blog - November 13, 2013 Category: Cancer Tags: exercise medication pharmaceutical manufacturers recommendations Source Type: blogs

Top stories in health and medicine, May 4, 2015
From MedPage Today: Statins Linked to Improved Lung Cancer Survival. Sustained statin use was associated with modestly better survival in lung cancer, an observational study in Great Britain showed. MRI-Detected Bone Marrow Changes Linked to Low Back Pain. Vertebral subchondral bone marrow changes visible on magnetic resonance imaging (MRI), known as modic changes, of the M1 type are positively correlated with low back symptoms. Slow Medicine: MOC in the Middle. The American Board of Internal Medicine (ABIM) has received a fair amount of criticism from U.S. internists and subspecialists because of its imposition of antiq...
Source: Kevin, M.D. - Medical Weblog - May 4, 2015 Category: Journals (General) Authors: Tags: News Cancer Source Type: blogs

My Husband Outlived His Brain Tumor Prognosis by 12 Years: How His Experience Could Help John McCain and Others
In conclusion, I would never advise John McCain and his family, or any other GBM patient, as to which of these treatments—or which combination of treatments—they should use. I hope they will learn about all of them, and decide on their own which one or ones they would like to try. I would also encourage them to do their own research, or to hire a researcher with experience in finding sensible, science-based, cutting-edge treatments. I am very worried that they will not know about these treatments, and others like them, and will just use the standard of care. That would be a shame. It might also be a death sentence.
Source: HONEST MEDICINE: My Dream for the Future - September 22, 2017 Category: Consumer Health News Authors: JuliaS1573 at aol.com (Julia Schopick) Source Type: blogs